--Objectives: The University of Colorado Health Sciences Center Division of Pulmonary Sciences and Critical Care Medicine is dedicated to the training of clinically skilled research-oriented physicians for careers in lung-disease based clinical, translation and basic human disease research. This NHLBI sponsored program, currently in its 29th year, has remained focused on training physicians. This is accomplished by a multidisciplinary approach to research training and a mentoring plan ascribed to by a distinguished participating faculty with an exceptional record of extramural support and training record. As in the past, our major objective is the development of academic and scientific leaders of the future in lung diseases. -Research Design: The training faculty consists of 34 MD and 16 PhD mentors as well as 21 pre-mentors. These individuals collaborate in 17 center grants (SCORE, SPORE, Program Project) and over 50 individual grants totaling over $35 million in annual direct costs. These resources allow the T32 trainee to select any lung disease focus and choose clinical outcomes/epidemiologic, translation or human disease basic/translational investigation. The clinical tracts are supported by didactic training in either the Clinical Science Program which leads to a PhD or certificate degree in the Graduate School or a MSPH degree in the Department of Public Health. The research training takes place on 3 campuses (UCSOM, VAMC, and NJRMC). Because of the diversity of the training faculty's research interests, any area of human lung disease can be studied by the trainee in clinical, translations! and human basic research tracts. -Program: The majority of T32 trainees are selected from the Clinical Pulmonary/Critical Care fellowship at UCHSC. This program receives over 300 applications yearly and interviews between 45-55 candidates from internal medicine programs across the country. The occasional post-doctoral PhD candidate is selected from approved graduate programs nationwide. Candidates are selected for the T32 program based on their recommendations, academic record and commitment to an academic career. The principal investigator, with advice from the co-principal investigators and oversight committees is responsible for the administration and coordination of the program.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Hippensteel, Joseph A; Schmidt, Eric P (2018) Sequestering Damage-associated Molecular Patterns in Critical Illness. A Novel Homeostatic Role for the Erythrocyte. Am J Respir Crit Care Med 197:416-418
McCubbrey, Alexandra L; Barthel, Lea; Mohning, Michael P et al. (2018) Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis. Am J Respir Cell Mol Biol 58:66-78
Ramadurai, Deepa; Kelmenson, Daniel A; Smith, Joshua et al. (2017) Progressive Dyspnea and Back Pain after Complicated Pneumonia. Ann Am Thorac Soc 14:1714-1717
McCubbrey, Alexandra L; Allison, Kristen C; Lee-Sherick, Alisa B et al. (2017) Promoter Specificity and Efficacy in Conditional and Inducible Transgenic Targeting of Lung Macrophages. Front Immunol 8:1618
Neumeier, Anna; Nordon-Craft, Amy; Malone, Dan et al. (2017) Prolonged acute care and post-acute care admission and recovery of physical function in survivors of acute respiratory failure: a secondary analysis of a randomized controlled trial. Crit Care 21:190
Janssen, William J; Stefanski, Adrianne L; Bochner, Bruce S et al. (2016) Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions. Eur Respir J 48:1201-1214
Mathai, Susan K; Pedersen, Brent S; Smith, Keith et al. (2016) Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 193:1151-60
Biehl, Jason R; Burnham, Ellen L (2015) Cannabis Smoking in 2015: A Concern for Lung Health? Chest 148:596-606
Mathai, Susan K; Schwartz, David A (2015) Taking the ""I"" out of IPF. Eur Respir J 45:1539-41
Honda, Jennifer R; Bernhard, Jon N; Chan, Edward D (2015) Natural disasters and nontuberculous mycobacteria: a recipe for increased disease? Chest 147:304-308

Showing the most recent 10 out of 74 publications